Indonesian Company, Afi Farma Officials Jailed Over Deadly Cough Syrup

Jakarta: An Indonesian court sentenced to jail on Wednesday the CEO and three other officials of a company whose cough syrup has been linked to the death of more than 200 children, for violating drug safety laws, the company’s lawyer said.

The Indonesian company, Afi Farma, was accused of producing cough syrups containing excess amounts of toxic material. Prosecutors charged the four officials for “consciously” not testing the ingredients, despite having the means and responsibility to do so, according to the charge sheet.

The company’s lawyer, Reza Wendra Prayogo, said they deny negligence and the company is considering whether to appeal.

The officials, including CEO Arief Prasetya Harahap, were sentenced to two years in prison by a court in the town of Kediri, in East Java province, where the company is based.

Prosecutors, who had sought up to nine years in prison for the accused, said that Afi Farma did not test the ingredients sent by its supplier and instead relied on certificates provided by them regarding product quality and safety.

Reza said in October that Indonesia’s drug regulator, BPOM, did not require drugmakers to do rigorous testing of ingredients.

The case comes as efforts grow worldwide to tighten oversight of drug supply chains after a wave of poisonings linked to contaminated cough syrups that killed dozens of children in countries such as Gambia and Uzbekistan.

Related Posts

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

The Central Drugs Standard Control Organisation (CDSCO) found one spurious and 220 not of standard quality (NSQ) drug samples from a batch tested randomly as part of the August drug…

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

The action follows the department’s investigation into a large-scale unlicenced drug repacking and relabelling racket uncovered at a farmhouse in Bengaluru South district’s Bidadi on August 18. The Karnataka Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman